The blood–brain barrier (BBB) is meant to protect the brain from noxious agents; however, it also significantly hinders the delivery of therapeutics to the brain. Several strategies have been employed ...
Denali co-founder and CEO Ryan Watts, Ph.D., to deliver opening plenary address at 2026 AAIC in London on July 12, 2026Presentation will ...
Glioblastoma multiforme (GBM), the most common type of malignant brain tumor, has a very high mortality rate, due in part to ...
New antibody technology improves RNA therapy delivery across the blood–brain barrier using engineered antibody targeting ...
MPS II, also called Hunter syndrome, is a rare genetic disease that affects over 2,000 individuals, primarily males, world-wide, and leads to behavioral, cognitive, and physical symptoms ultimately ...
Announcing a new review article publication for Acta Materia Medica journal. Peptides are short chains of amino acids linked by peptide bonds. Many peptides and proteins are limited by their poor ...
A newly published study in Oncoscience explored a potential new approach to treating glioblastoma, an aggressive form of ...
When faced with chronic stress, why do some people develop anxiety and depressive symptoms while others show resilience? The results of studies in mice, headed by researchers at Université Laval, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results